| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |